west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "肾脏损害" 3 results
  • 心脏直视手术围术期尿微量蛋白变化的临床观察

    目的 观察心脏直视手术围术期尿微量蛋白的变化并分析其临床意义.方法 40例心脏直视手术患者按疾病种类不同分为两组,组Ⅰ:风湿性心脏病瓣膜置换术患者(n=20);组Ⅱ:非紫绀型先天性心脏病患者(n=20).采用速率散射比浊法分别于术前1天,手术结束时,术后1天,术后3天和术后5天测定微白蛋白、转铁蛋白、免疫球蛋白G和α1-微球蛋白的浓度变化.结果 两组术后微白蛋白、转铁蛋白、免疫球蛋白G和α1-微球蛋白的浓度均明显升高(P<0.05或P<0.01),到达峰值后逐渐下降.两组比较,组Ⅰ术后改变较明显,持续时间也较长(P<0.05或P<0.01).结论 心脏直视术后存在不同程度的肾脏损害,风湿性心脏病瓣膜置换术患者术后的肾脏损害较重.尿微量蛋白测定可以敏感、准确地发现心脏直视术后亚临床肾脏损害.

    Release date:2016-08-30 06:35 Export PDF Favorites Scan
  • 抗磷脂综合征肾损害

    抗磷脂综合征(APS)是一种以动静脉血栓反复形成、病态妊娠及抗磷脂抗体持续阳性为特征的疾病。APS的发病与多种自身抗体相关,如抗心磷脂抗体、抗β-2糖蛋白-1抗体、抗凝血酶原抗体等。临床上根据有无合并其他自身免疫性疾病,分为原发性APS和继发性APS。APS可累及全身各个器官,无论是原发性还是继发性APS,肾脏均是其损害的主要靶器官,肾内各级血管,包括肾动脉主干及其分支,肾小球毛细血管及肾静脉均可出现血栓。APS肾损害的临床表现复杂多样,但缺乏特异性,因此临床诊断比较困难,误诊、漏诊率高,也给治疗带来很大麻烦。APS可导致终末期肾病及移植肾功能不全,一旦诊断明确需要长期抗凝治疗以预防血栓事件,一些新的药物如利妥昔单抗、雷帕霉素等被发现可能对APS有效。

    Release date: Export PDF Favorites Scan
  • Efficacy of Amlodipine for Diabetes Mellitus Combined with Hypertension and Renal Impairment: A Systematic Review

    ObjectiveTo systematically review the efficacy of amlodipine versus valsartan in the treatment of diabetes mellitus combined with hypertension and renal impairment. MethodsAll relevant randomized controlled trials (RCTs) were retrieved in WanFang Data, CNKI, VIP, CBM, The Cochrane Library (Issue 10, 2013), PubMed, EMbase and Ovid up to October 2013. Two reviewers independently screened literature according to the inclusion and exclusion criteria, extracted data, and assessed the methodological quality of included studies. Then meta-analysis was performed using RevMan 5.2. ResultsNine RCTs were finally included involving 794 cases. The results of meta-analysis showed that amlodipine was better than valsartan in improving 24-hour proteinuria (basic level < 1 000 mg:WMD=-10.24, 95%CI-18.52 to-1.95, P=0.02; basic level > 1 000 mg:WMD=-575.69, 95%CI-781.02 to-370.36, P < 0.000 01). However, there was no significant difference between two groups in lowing urine albumin excretion rates (UAER), serum creatinine (Scr), systolic blood pressure (SBP), diastolic blood pressure (DBP), and incidences of adverse events (UAER:WMD=-11.29, 95%CI-27.93 to 5.36, P=0.18; Scr:WMD=1.05, 95%CI-3.89 to 5.99, P=0.68; SBP:WMD=0.52, 95%CI-0.83 to 1.87, P=0.45; DBP:WMD=-0.40, 95%CI-1.41 to 0.62, P=0.44; ADR:WMD=1.00, 95%CI 0.3 to 3.34, P=1.00). ConclusionCurrent evidence shows that, compared with valsartan, amlodipine has the same efficacy in treatment of diabetes mellitus combined with hypertension and renal impairment, and it is even better in improving 24-hour proteinuria.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content